Long Neuro-COVID-19: Current Mechanistic Views and Therapeutic Perspectives

Anny Slama Schwok (1, 2) , Julien Henri (3)

1 CRSA - Centre de Recherche Saint-Antoine
2 CHU Saint-Antoine [AP-HP]
3 LCQB - Biologie Computationnelle et Quantitative = Laboratory of Computational and Quantitative Biology

Long-lasting COVID-19 (long COVID) diseases constitute a real life-changing burden for many patients around the globe and, overall, can be considered societal and economic issues. They include a variety of symptoms, such as fatigue, loss of smell (anosmia), and neurological–cognitive sequelae, such as memory loss, anxiety, brain fog, acute encephalitis, and stroke, collectively called long neuro-COVID-19 (long neuro-COVID). They also include cardiopulmonary sequelae, such as myocardial infarction, pulmonary damage, fibrosis, gastrointestinal dysregulation, renal failure, and vascular endothelial dysregulation, and the onset of new diabetes, with each symptom usually being treated individually. The main unmet challenge is to understand the mechanisms of the pathophysiologic sequelae, in particular the neurological symptoms. This mini-review presents the main mechanistic hypotheses considered to explain the multiple long neuro-COVID symptoms, namely immune dysregulation and prolonged inflammation, persistent viral reservoirs, vascular and endothelial dysfunction, and the disruption of the neurotransmitter signaling along various paths. We suggest that the nucleoprotein N of SARS-CoV-2 constitutes a “hub” between the virus and the host inflammation, immunity, and neurotransmission.

Keywords: long COVID; brain fog; inflammation; mitochondrial dysfunction; immunity; viral reservoirs; nucleoprotein; neurotransmission; substance P; enkephalin Conceptualization

Domains: Life Sciences [q-bio]

Anny Slama Schwok, Julien Henri. Long Neuro-COVID-19: Current Mechanistic Views and Therapeutic Perspectives. Biomolecules, 2024, 14 (9), pp.1081. ⟨10.3390/biom14091081⟩. ⟨hal-04718116⟩